+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Critical Care Diagnostics Market by Test, End-User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 195 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5337076
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Critical Care Diagnostics Market grew from USD 1.23 billion in 2023 to USD 1.45 billion in 2024. It is expected to continue growing at a CAGR of 17.97%, reaching USD 3.91 billion by 2030.

The critical care diagnostics market encompasses a range of medical tests and procedures used to diagnose patients in critical or intensive care settings swiftly. The necessity of these diagnostics lies in their ability to provide rapid, accurate information that is crucial for timely decision-making in life-threatening situations. Applications include monitoring vital signs, blood gas analysis, infection detection, and organ function assessment. End-use primarily occurs in hospitals, emergency rooms, and intensive care units (ICUs), but there is a rising trend of use in ambulatory surgical centers and home care settings due to advancements in portable diagnostic technologies.

Market growth is significantly influenced by factors such as the increasing prevalence of chronic diseases, rising healthcare expenditure, advancements in diagnostic technologies, and a growing aging population that requires critical care. Potential opportunities are driven by the expansion of telemedicine, which integrates remote diagnostics, and the development of AI-driven diagnostic tools that enhance accuracy and efficiency. Moreover, the growing adoption of point-of-care testing (POCT) facilitates immediate testing at the patient's side, benefiting healthcare environments seeking faster results and improved patient management.

However, challenges include high costs of advanced diagnostic equipment, the need for skilled professionals to operate complex machinery, and strict regulatory requirements that slow down innovation. Limited awareness in developing regions further hampers market growth. To overcome these challenges, investing in training and development of healthcare personnel and enhancing cost efficiencies for widespread adoption are recommended.

The best areas for innovation and research include AI integration for predictive analytics, the development of miniaturized diagnostic devices, and creating more robust and cost-effective POCT systems. The market is dynamic, characterized by rapid technological advancements and heightened competition, necessitating stakeholders to continuously innovate and adapt to new trends. By focusing on these areas, businesses can better position themselves in the evolving landscape of critical care diagnostics.

Understanding Market Dynamics in the Critical Care Diagnostics Market

The Critical Care Diagnostics Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Rising geriatric population worldwide and prevalence of chronic diseases
    • Increasing demand for rapid diagnosis and treatment
    • Growth in data management and connectivity to Electronic Health Record (EHR)
  • Market Restraints
    • High cost of diagnostics tools
  • Market Opportunities
    • Government activities and support for implementing critical care diagnostics
    • Rising remote communications between diagnostics and laboratories
  • Market Challenges
    • Lack of Skilled Professionals

Exploring Porter’s Five Forces for the Critical Care Diagnostics Market

Porter’s Five Forces framework further strengthens the insights of the Critical Care Diagnostics Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Critical Care Diagnostics Market

External macro-environmental factors deeply influence the performance of the Critical Care Diagnostics Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Critical Care Diagnostics Market

The Critical Care Diagnostics Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Critical Care Diagnostics Market

The Critical Care Diagnostics Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Critical Care Diagnostics Market

The Critical Care Diagnostics Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Critical Care Diagnostics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Bayer Healthcare AG, Becton, Dickinson & Company, Danaher Corporation, EKF Diagnostics Holdings PLC, F. Hoffmann-La Roche AG, General Electric Company, HORIBA, Ltd., Johnson and Johnson Service, Inc., Medcaptain Medical Technology Co., Ltd, Medtronic PLC, Omron Corporation, Roche Diagnostics Ltd., Sysmex Corporation, and WerfenLife, S.A..

Market Segmentation & Coverage

This research report categorizes the Critical Care Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Test
    • Coagulation Testing
    • Flow Cytometry
    • Hematology
    • Immunoproteins
    • Microbial & Infectious Diseases
    • Routine & Special Chemistry
  • End-User
    • Emergency Rooms
    • Intensive Care Units
    • Operation Rooms
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising geriatric population worldwide and prevalence of chronic diseases
5.1.1.2. Increasing demand for rapid diagnosis and treatment
5.1.1.3. Growth in data management and connectivity to Electronic Health Record (EHR)
5.1.2. Restraints
5.1.2.1. High cost of diagnostics tools
5.1.3. Opportunities
5.1.3.1. Government activities and support for implementing critical care diagnostics
5.1.3.2. Rising remote communications between diagnostics and laboratories
5.1.4. Challenges
5.1.4.1. Lack of Skilled Professionals
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Critical Care Diagnostics Market, by Test
6.1. Introduction
6.2. Coagulation Testing
6.3. Flow Cytometry
6.4. Hematology
6.5. Immunoproteins
6.6. Microbial & Infectious Diseases
6.7. Routine & Special Chemistry
7. Critical Care Diagnostics Market, by End-User
7.1. Introduction
7.2. Emergency Rooms
7.3. Intensive Care Units
7.4. Operation Rooms
8. Americas Critical Care Diagnostics Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Critical Care Diagnostics Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Critical Care Diagnostics Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. Market Share Analysis, 2023
11.2. FPNV Positioning Matrix, 2023
11.3. Competitive Scenario Analysis
11.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. CRITICAL CARE DIAGNOSTICS MARKET RESEARCH PROCESS
FIGURE 2. CRITICAL CARE DIAGNOSTICS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2023 VS 2030 (%)
FIGURE 7. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 9. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. AMERICAS CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 11. AMERICAS CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. UNITED STATES CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 13. UNITED STATES CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. ASIA-PACIFIC CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. ASIA-PACIFIC CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. EUROPE, MIDDLE EAST & AFRICA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. CRITICAL CARE DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 19. CRITICAL CARE DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. CRITICAL CARE DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. CRITICAL CARE DIAGNOSTICS MARKET DYNAMICS
TABLE 7. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY COAGULATION TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY IMMUNOPROTEINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY MICROBIAL & INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY ROUTINE & SPECIAL CHEMISTRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY EMERGENCY ROOMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY INTENSIVE CARE UNITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY OPERATION ROOMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. AMERICAS CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 19. AMERICAS CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 21. ARGENTINA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 22. ARGENTINA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 23. BRAZIL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 24. BRAZIL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 25. CANADA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 26. CANADA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 27. MEXICO CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 28. MEXICO CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 29. UNITED STATES CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 30. UNITED STATES CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 31. UNITED STATES CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 32. ASIA-PACIFIC CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 33. ASIA-PACIFIC CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 34. ASIA-PACIFIC CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 35. AUSTRALIA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 36. AUSTRALIA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 37. CHINA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 38. CHINA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 39. INDIA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 40. INDIA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 41. INDONESIA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 42. INDONESIA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 43. JAPAN CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 44. JAPAN CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 45. MALAYSIA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 46. MALAYSIA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 47. PHILIPPINES CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 48. PHILIPPINES CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 49. SINGAPORE CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 50. SINGAPORE CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 51. SOUTH KOREA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 52. SOUTH KOREA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 53. TAIWAN CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 54. TAIWAN CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 55. THAILAND CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 56. THAILAND CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 57. VIETNAM CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 58. VIETNAM CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 59. EUROPE, MIDDLE EAST & AFRICA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 60. EUROPE, MIDDLE EAST & AFRICA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 61. EUROPE, MIDDLE EAST & AFRICA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 62. DENMARK CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 63. DENMARK CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 64. EGYPT CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 65. EGYPT CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 66. FINLAND CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 67. FINLAND CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 68. FRANCE CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 69. FRANCE CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 70. GERMANY CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 71. GERMANY CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 72. ISRAEL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 73. ISRAEL CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 74. ITALY CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 75. ITALY CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 76. NETHERLANDS CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 77. NETHERLANDS CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 78. NIGERIA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 79. NIGERIA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 80. NORWAY CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 81. NORWAY CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 82. POLAND CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 83. POLAND CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 84. QATAR CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 85. QATAR CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 86. RUSSIA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 87. RUSSIA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 88. SAUDI ARABIA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 89. SAUDI ARABIA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 90. SOUTH AFRICA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 91. SOUTH AFRICA CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 92. SPAIN CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 93. SPAIN CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 94. SWEDEN CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 95. SWEDEN CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 96. SWITZERLAND CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 97. SWITZERLAND CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 98. TURKEY CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 99. TURKEY CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 100. UNITED ARAB EMIRATES CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 101. UNITED ARAB EMIRATES CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 102. UNITED KINGDOM CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 103. UNITED KINGDOM CRITICAL CARE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 104. CRITICAL CARE DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 105. CRITICAL CARE DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Critical Care Diagnostics Market, which are profiled in this report, include:
  • Abbott Laboratories
  • Bayer Healthcare AG
  • Becton, Dickinson & Company
  • Danaher Corporation
  • EKF Diagnostics Holdings PLC
  • F. Hoffmann-La Roche AG
  • General Electric Company
  • HORIBA, Ltd.
  • Johnson and Johnson Service, Inc.
  • Medcaptain Medical Technology Co., Ltd
  • Medtronic PLC
  • Omron Corporation
  • Roche Diagnostics Ltd.
  • Sysmex Corporation
  • WerfenLife, S.A.

Methodology

Loading
LOADING...

Table Information